Medical Marketing in the US, Effect of Antiplatelet Co-Pay Vouchers on CVD Outcomes, Linagliptin and CVD in T2DM, and more

JAMA Editor’s Summary

Medical Marketing in the US, Effect of Antiplatelet Co-Pay Vouchers on CVD Outcomes, Linagliptin and CVD in T2DM, and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 01/08, 2019 issue

January 8, 2019

Listen on your favorite player Take me to this show’s page

Newer →

Effect of FMT on Ulcerative Colitis, HSCT for MS, Review of Penicillin Allergy, and more

← Older

Medicare's HRRP and Mortality, Knee Arthritis Pain Control, Management of In-Flight Medical Emergencies, Best of Graphic Medicine 2018, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Medical Marketing in the US, Effect of Antiplatelet Co-Pay Vouchers on CVD Outcomes, Linagliptin and CVD in T2DM, and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 01/08, 2019 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00